Glycos Biotechnologies to Present at the International Biomass Conference and Expo

Share Article

Biochemical Executive to Discuss Globalization of Biomass Feedstocks - Offering a First-Hand Perspective from the Company’s Malaysian Biochemical Facility

Rob Toker, VP, Market Research and Partnerships, GlycosBio

Global Perspectives on Biomass Based Energy Opportunities

Glycos Biotechnologies, Inc. (GlycosBio), an international biochemical company commercializing advanced biological processes that convert low-value feedstocks into high-value sustainable chemicals, today announced the Company will present at the International Biomass Conference and Expo taking place May 2nd – 5th in St. Louis, MO.

Rob Toker, Vice President of Partnerships and Market Research, will participate on a panel with industry experts from biomass to power, thermal and fuel operations exploring the global opportunities for each energy pathway. As the biomass industry expands, the marketplace for technologies, services and biomass feedstocks is becoming global. The panel will examine how globalization is already unfolding in the industry.

Toker will offer a first-hand perspective of biomass globalization by providing attendees with an overview of GlycosBio’s international industrial biochemical plant and biochemical research and development facility in Bio-XCell, a dedicated biotechnology park located in Malaysia. As part of this overview, Toker will address how GlycosBio renewable chemicals can be used as drop in replacements for petrochemicals that integrate seamlessly with existing industrial supply chains, many of which are located globally, ultimately offering the highest and best use of sustainable biomass carbon sources.

In addition, Toker will discuss how optimizing the full economic potential of renewable natural resources is a key design criteria for GlycosBio and its project partners. For example, at the Company’s commercial plant, GlycosBio is contracting steam and power utilities from a biomass fired CHP system. The Central Utility Facility (CUF) allows GlycosBio to further reduce its emissions impact and overall lifecycle costs as compared to the traditional petroleum derived chemical building blocks and intermediates.

Organized by BBI International and coproduced by Biomass Power & Thermal and Biorefining Magazine, the International Biomass Conference and Expo brings current and future producers of bioenergy and biobased products together with waste generators, energy crop growers, municipal leaders, utility executives, technology providers, equipment manufacturers, project developers, investors and policy makers. It’s a true one-stop shop – the world’s premier educational and networking junction for all biomass industries.

“Global Perspectives on Biomass Based Energy Opportunities”


Richard Weiner, Vice President, Fredrikson & Byron P.A.

Jean-Paul Crouzoulon, Senior Vice President, Operations, AREVA Renewables North America
“Applying Global Biopower Experience in Building the U.S. Industry”

Bengt-Erik Löfgren, Chief Executive Officer, ÄFAB Älvdalens Fastbränsle AB - Sweden
“Key Issues for Pellet Market Development in Sweden”

John Keppler, Chairman and Chief Executive Officer, Enviva LP
“Perspectives on Woody Biomass”

Rob Toker, Vice President, Partnerships and Market Research, Glycos Biotechnologies, Inc.
“International Project Development for the ‘Born Global’ Company”

America’s Center, St. Louis, MO

Date and Time
Tuesday, May 3rd, 1:30pm

For more information about the International Biomass Conference and Expo, visit

About Glycos Biotechnologies, Inc.
Glycos Biotechnologies, Inc. (“GlycosBio”) is an international biochemical company commercializing advanced metabolic engineering and microbial strain processes that convert multiple low value feedstocks into a range of high value sustainable chemicals. By designing a portfolio of differentiated microorganisms, GlycosBio’s bioconversion technology produces a diverse set of chemicals, including substitutes for fossil fuel derived petrochemicals, meeting the growing global demand for clean, environmentally safe biochemicals.

GlycosBio is privately held and focused on biochemical commercialization and production with established global partnerships including relationships with petrochemical companies to secure low cost, non-petroleum based chemicals. For more information, visit

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Suzanne Tormollen
Glycos Biotechnologies, Inc.
(281) 785-1280
Email >